Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Proprius Pharmaceuticals logo — A San Diego innovator specializing in rheumatology and autoi...

Proprius Pharmaceuticals

A San Diego innovator specializing in rheumatology and autoimmune care, offering promising early-stage treatments for pain and rheumatoid arthritis since 2005.

Founded 2005 Series A Total: $11.00M Biotechnology, Pharmaceutical

General Information

Company Name Proprius Pharmaceuticals
Founded Year 2005
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Proprius Pharmaceuticals. To contact Proprius Pharmaceuticals, visit propriuspharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Proprius Pharmaceuticals compare?

A PDF of Proprius Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Proprius Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Proprius Pharmaceuticals

Proprius Pharmaceuticals, a San Diego-based biotechnology and pharmaceutical company, has been a pioneering force in the field of rheumatology and autoimmune care since its establishment in 2005. Specializing in the development of drugs for these ailments, Proprius Pharmaceuticals is currently advancing two early-stage therapeutic candidates, one targeting pain management and the other focusing on rheumatoid arthritis treatment. With a $11.00M Series A investment received on 08 January 2007, the company's noteworthy investors include Atlas Venture, Forward Ventures, Fog City Capital, Windamere Venture Partners, and CDIB BioScience Ventures. Proprius Pharmaceuticals continues to be devoted to creating innovative solutions in the medical field, making significant strides in tackling these complex and impactful conditions.

Business keywords: Rheumatology, Autoimmune care, Drug development, Pain treatment, Rheumatoid arthritis, San Diego, Biopharmaceuticals, Innovation, Early-stage treatments, Therapeutic candidates

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $11.00M 5
Atlas Venture Forward Ventures Fog City Capital
Atlas Venture, Forward Ventures +3
08 Jan 2007

Proprius Pharmaceuticals Alternatives & Competitors

View All Alternatives
Proprius Pharmaceuticals vs
Synta Pharmaceuticals
Synta Pharmaceuticals

Innovating patient care with advanced small molecule therapies for severe medical conditions, includ...

Post-IPO Equity
Biotechnology, Health Care
Proprius Pharmaceuticals vs
Inflammx Therapeutics, Inc.
Inflammx Therapeutics, Inc. United States

Modulation of Inflammasome mediated Autoinflammation - in Ophthalmology, Nephropathy and Neurodegen...

Venture round
3 employees
Biotechnology, Health Care
Proprius Pharmaceuticals vs
LIPUM AB
LIPUM AB Sweden

We have developed a biological drug SOL-116 for treatment of chronic inflammatory diseases

Post-IPO Equity
15 employees
Biotechnology, Health Care
View all alternatives

FAQ About Proprius Pharmaceuticals

A San Diego innovator specializing in rheumatology and autoimmune care, offering promising early-stage treatments for pain and rheumatoid arthritis since 2005.
Proprius Pharmaceuticals was founded in 2005.
Proprius Pharmaceuticals operates in Biotechnology and Pharmaceutical. Its work centres on Rheumatology, Autoimmune care, Drug development and Pain treatment.
Proprius Pharmaceuticals has completed 1 funding round, raising a total of $11.00M. The latest funding stage is Series A.
Top alternatives and competitors to Proprius Pharmaceuticals include Synta Pharmaceuticals, Inflammx Therapeutics, Inc., LIPUM AB, Oxagen, Hoba Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Proprius Pharmaceuticals and Synta Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Proprius Pharmaceuticals, https://bouncewatch.com/company/proprius-pharmaceuticals, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout